Research in Mechanisms of Action Regarding Inhibitory Effects of Interferon-γ and -β in Intracellular Signal Transduction.
干扰素-γ和-β对细胞内信号转导的抑制作用的作用机制研究。
基本信息
- 批准号:14570569
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Purpose :Though idiopathic pulmonary fibrosis(IPF) is fatal disease in field of diffuse lung diseases, no effective treatment improving prognosis has been reported. Interferons will be promising for treatment in fibrotic disorders in pulmonary disease, however, Interferon-β has been failed to improve survival ratio of IPF and interferon-γ fairly improved %VC in early stage of IPF (%VC>60%). Based on these clinical situations, we investigated mechanism of action of interferon-□ in bleomycin induced pulmonary fibrosis.Methods :Bleomycin at day 0 and interferon-β for 4 weeks were administered intravenously to ICR mice. At 28 days after bleomycin injection, histological and chemical analysis was performed for evaluation of effects of interferon-β. Tissue distribution and amounts of TGF-β1 and thrombospondin-1/2 were analyzed.Results and Discussion :Interferon-β□ attenuated prolylhydroxylase activity, resulting in inhibition of pulmonary fibrosis. Bleomycin-induced increase in TGF-β1 in epithelial cells and extracellular matrix was attenuated by interferon-β. Thrombospondin-1/2 was limited in platelets of control mice, but was present in foamy cells in fibrotic regions induced by bleomycin. In vitro study, IFN-g (10-1000ug/ml) did not inhibit growth of HMg2980 lung fibroblast cell line under no stimulation, but inhibited TGF-β1-induced proliferation of HMg2980 cell line.These findings suggest that the antifibrotic effect of interferon-β□ is inhibition of TGF-βand its activation via decrease in thrombospondin-1/2 in lung tissue and change in location of thrombospondin-1/2 from platelets to foamy cells. IFN-β and IFN-γ will be promising agents in different mechanisms to inhibit fibroblast proliferation.
目的:特发性肺纤维化(idiopathic pulmonary fibrosis, IPF)是弥漫性肺疾病领域的致死性疾病,但目前尚无改善预后的有效治疗方法。干扰素有望用于肺疾病纤维化疾病的治疗,然而,干扰素-β未能提高IPF的生存率,干扰素-γ相对改善IPF早期的%VC (%VC bb0 60%)。基于这些临床情况,我们探讨干扰素-□在博来霉素诱导肺纤维化中的作用机制。方法:ICR小鼠第0天静脉给予博来霉素,第4周静脉给予干扰素β。注射博来霉素后28 d,进行组织学和化学分析,评价干扰素-β的作用。分析TGF-β1、血栓反应蛋白-1/2的组织分布及含量。结果与讨论:干扰素β□可减弱脯氨酸羟化酶活性,从而抑制肺纤维化。博莱霉素诱导的上皮细胞和细胞外基质中TGF-β1的升高被干扰素-β减弱。血小板反应蛋白-1/2在对照小鼠的血小板中有限,但在博来霉素诱导的纤维化区域的泡沫细胞中存在。体外研究发现,在不刺激的情况下,IFN-g (10-1000ug/ml)不抑制HMg2980肺成纤维细胞株的生长,但抑制TGF-β1诱导的HMg2980细胞株的增殖。这些结果表明,干扰素β□的抗纤维化作用是通过抑制TGF-β及其激活,减少肺组织中血小板-1/2的表达,改变血小板-1/2向泡沫细胞的位置。IFN-β和IFN-γ将在不同机制下抑制成纤维细胞增殖。
项目成果
期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Editorial: Shared Mechanisms of Lung Injury and Subsequent Fibrosis. -Role of Surfactant Proteins in the Pathogenesis of Interstitial Pneumonia in Hermansky-Pudlak Syndrome-
社论:肺损伤和随后的纤维化的共同机制。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:A Azuma
- 通讯作者:A Azuma
Interferon-βInhibits Bleomycin-Induced Lung Fibrosis by Decreasing TGF-β and Thrombospondin.
干扰素-β 通过减少 TGF-β 和血小板反应蛋白抑制博来霉素诱导的肺纤维化。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:A Azuma;YJ Li;etc.
- 通讯作者:etc.
Interferon-□ Inhibits Bleomycin-Induced Lung Fibrosis by Decreasing TGF-β and Thrombospondin.
干扰素-□ 通过减少 TGF-β 和血小板反应蛋白抑制博来霉素诱导的肺纤维化。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:A Azuma;YJ Li;J Usuki;S Abe;K Matsuda;S Henmi;Y Miyauchi;A Izawa;S Sone;S Hashimoto;S Kudoh
- 通讯作者:S Kudoh
The effects of inhalation of diesel exhaust on murine mycobacterial infection
- DOI:10.1080/01902140590918786
- 发表时间:2005-05-01
- 期刊:
- 影响因子:1.7
- 作者:Hiramatsu, K;Saito, Y;Sugawara, I
- 通讯作者:Sugawara, I
Shared Mechanisms of Lung Injury and Subsequent Fibrosis. -Role of Surfactant Proteins in the Pathogenesis of Interstitial Pneumonia in Hermansky-Pudlak Syndrome-
肺损伤和随后的纤维化的共同机制。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:A Azuma;Editorial
- 通讯作者:Editorial
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AZUMA Arata其他文献
AZUMA Arata的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AZUMA Arata', 18)}}的其他基金
Involvement of bone marrow-derived fibrocyte in the pathogenesis of pulmonary fibrosis and the effect of newly developed anti-fibrotic agents
骨髓源性纤维细胞参与肺纤维化发病机制及新开发的抗纤维化药物的作用
- 批准号:
23591163 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of Inhibition of Inflammatory Cell Migration into Lung Tissue by Ammeriolation of Cell Adhesion on Vascular Endothelial Cell
血管内皮细胞上细胞粘附的氨化作用抑制炎症细胞迁移至肺组织的研究
- 批准号:
12670581 - 财政年份:2000
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
INTERFERON B-7A IN THE TREATMENT OF SYSTEMIC SCLERODERMA
干扰素 B-7A 治疗系统性硬皮病
- 批准号:
7206254 - 财政年份:2004
- 资助金额:
$ 2.05万 - 项目类别:
Interferon B-7a in the Treatment of Systemic Scleroderma
干扰素 B-7a 治疗系统性硬皮病
- 批准号:
7042173 - 财政年份:2003
- 资助金额:
$ 2.05万 - 项目类别:
Immunomodulation in Multiple Sclerosis by Interferon B
干扰素 B 对多发性硬化症的免疫调节
- 批准号:
6545039 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
Immunomodulation in Multiple Sclerosis by Interferon B
干扰素 B 对多发性硬化症的免疫调节
- 批准号:
6784026 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
Immunomodulation in Multiple Sclerosis by Interferon B
干扰素 B 对多发性硬化症的免疫调节
- 批准号:
6663195 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
Immunomodulation in Multiple Sclerosis by Interferon B
干扰素 B 对多发性硬化症的免疫调节
- 批准号:
6927050 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
INTERFERON-B AND COPOLYMER-I IN MULTIPLE SCLEROSIS.
多发性硬化症中的干扰素-B 和共聚物-I。
- 批准号:
6539485 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
INTERFERON-B AND COPOLYMER-I IN MULTIPLE SCLEROSIS.
多发性硬化症中的干扰素-B 和共聚物-I。
- 批准号:
6187713 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
INTERFERON-B AND COPOLYMER-I IN MULTIPLE SCLEROSIS.
多发性硬化症中的干扰素-B 和共聚物-I。
- 批准号:
6834188 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
INTERFERON-B AND COPOLYMER-I IN MULTIPLE SCLEROSIS.
多发性硬化症中的干扰素-B 和共聚物-I。
- 批准号:
6393156 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别: